Metabolomic analyses uncover an inhibitory effect of niclosamide on mitochondrial membrane potential in cholangiocarcinoma cells
Background Niclosamide is an oral anthelminthic drug that has been used for treating tapeworm infections. Its mechanism involves the disturbance of mitochondrial membrane potential that in turn inhibits oxidative phosphorylation leading to ATP depletion. To date, niclosamide has been validated as th...
Main Authors: | Thanaporn Kulthawatsiri, Yingpinyapat Kittirat, Jutarop Phetcharaburanin, Jittima Tomacha, Bundit Promraksa, Arporn Wangwiwatsin, Poramate Klanrit, Attapol Titapun, Watcharin Loilome, Nisana Namwat |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2023-11-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/16512.pdf |
Similar Items
-
Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma
by: Yingpinyapat Kittirat, et al.
Published: (2022-08-01) -
The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models
by: Pimpawadee Phukhum, et al.
Published: (2023-02-01) -
CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression.
by: Malinee Thanee, et al.
Published: (2021-01-01) -
1H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism
by: Rujikorn Treeriya, et al.
Published: (2023-05-01) -
Metabolic Changes of Cholangiocarcinoma Cells in Response to Coniferyl Alcohol Treatment
by: Bundit Promraksa, et al.
Published: (2021-03-01)